HCPCS code J0219 — Inj aval alfa-nqpt 4mg. Status: Active. Effective Apr 1, 2022. Source: CMS HCPCS Level II.

J0219

Active

Inj aval alfa-nqpt 4mg

Injection, avalglucosidase alfa-ngpt, 4 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Apr 1, 2022
Code type: alphanumeric
OPPS Status: K — Non-pass-through drugs and biologicals
OPPS APC: 9433

MUE — Medically Unlikely Edits

Maximum units of J0219 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 750
Practitioner Services 750

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
58468-0426-01 Nexviazyme

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2022-Q2
    Inj aval alfa-nqpt 4mg